Khiron Life Sciences (KHRNF) Financial Statements
172 Followers
Khiron Life Sciences Financial Overview
Khiron Life Sciences's market cap is currently C$5.09M. The company's EPS TTM is C$-0.17; its P/E ratio is -0.20; Khiron Life Sciences has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 22 | Mar 21 | Mar 20 | Mar 19 | May 17 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | C$ 12.79M | C$ 8.02M | C$ 9.58M | C$ 891.68K | C$ 0.00 |
| Gross Profit | C$ 6.37M | C$ 7.01M | C$ 2.44M | C$ 297.36K | C$ 0.00 |
| Operating Income | C$ -19.79M | C$ -23.60M | C$ -37.43M | C$ -19.90M | C$ 0.00 |
| EBITDA | C$ -32.03M | C$ -22.32M | C$ -36.49M | C$ -18.29M | C$ -4.52M |
| Net Income | C$ -33.13M | C$ -24.04M | C$ -36.38M | C$ -19.81M | C$ 0.00 |
| Balance Sheet | |||||
| Cash & Short-Term Investments | C$ 8.92M | C$ 21.65M | C$ 36.90M | C$ 18.96M | C$ 147.52K |
| Total Assets | C$ 42.27M | C$ 73.18M | C$ 81.91M | C$ 40.35M | C$ 147.52K |
| Total Debt | C$ 2.23M | C$ 2.79M | C$ 3.55M | C$ 2.51M | C$ 0.00 |
| Net Debt | C$ -6.70M | C$ -18.86M | C$ -5.79M | C$ -12.51M | C$ -147.52K |
| Total Liabilities | C$ 8.95M | C$ 9.95M | C$ 11.87M | C$ 14.81M | C$ 12.62K |
| Stockholders' Equity | C$ 33.33M | C$ 63.23M | C$ 70.04M | C$ 25.54M | C$ 134.90K |
| Cash Flow | |||||
| Free Cash Flow | C$ -22.14M | C$ -27.23M | C$ -36.17M | C$ -18.60M | C$ -21.30K |
| Operating Cash Flow | C$ -20.40M | C$ -24.53M | C$ -30.07M | C$ -14.77M | C$ -21.30K |
| Investing Cash Flow | C$ -2.09M | C$ 24.87M | C$ -31.98M | C$ -9.22M | C$ 0.00 |
| Financing Cash Flow | C$ 10.89M | C$ 12.17M | C$ 57.00M | C$ 37.59M | C$ 5.00K |
Currency in CAD
